Search Contract Opportunities

Adaptive Optics (AO) Retinal Imaging System

ID: CDHR-2026-133666 • Type: Sources Sought • Match:  85%
Opportunity Assistant

Hello! Please let me know your questions about this opportunity. I will answer based on the available opportunity documents.

Please sign-in to link federal registration and award history to assistant. Sign in to upload a capability statement or catalogue for your company

Popular Questions:
Generate a draft:
Loading

Description

Refer to the attachments.

Background
The U.S. Food and Drug Administration (FDA) is seeking to acquire an Adaptive Optics (AO) Retinal Imaging System to support its mission of fostering and accelerating the clinical translation of innovative medical device technologies. This acquisition is crucial for evaluating and validating emerging retinal imaging technologies, developing regulatory science tools, and facilitating the assessment of novel biomarkers for future medical device applications.

The system will be deployed in the Optical Diagnostic Devices Laboratory of FDA/CDRH/OSEL/DBP to support ongoing studies under the ophthalmic devices program charter, particularly in characterizing performance and capabilities of optical diagnostic devices for retinal diseases.

Work Details
The contract involves the procurement of an Adaptive Optics (AO) Retinal Imaging System, which includes both hardware and software components. The system must meet the following salient characteristics:
- **Hardware Specifications:**
- Methodology: Pupillary reflectance imaging and non-contact transscleral flood illumination
- Light sources: Infrared LED and SLD (750 to 890 nm)
- Lateral resolution in tissue (optical): 2 — 3 µm
- Pixel pitch: 1 µm
- Focusing range in tissue: 300 µm
- Cellular View image field angle: >6.5° x 6.5°
- Fundus Overview image field angle: 30° x 30°
- Minimum pupil diameter: 4 mm
- Refractive error adjustment: +15 D to –15 D, continuous
- Acquisition time: <3 seconds
- Fixation targets: Internal and external
- **Software Requirements:**
- Simultaneous live widefield overview and cellular-level imaging
- Pupil alignment feedback
- Image comparison for follow-up examination
- **Electronic Interfaces:**
- Input voltage and frequency: 100 — 240 V, 50 — 60 Hz
- Power consumption (max): 450 W
- Dimensions (L x W x H): <= 65cm x 65cm x 65cm
- Weight: <= 60 kg

Place of Performance
Deliverables are to be sent to the U.S. Food and Drug Administration, CDRH/OSEL/DBP, located at 10903 New Hampshire Avenue, WO62 Room 1124, Silver Spring, MD.

Overview

Response Deadline
May 12, 2026, 10:00 a.m. EDT Past Due
Posted
May 5, 2026, 7:14 p.m. EDT
Set Aside
None
Place of Performance
Silver Spring, MD 20993 United States
Source

Current SBA Size Standard
1250 Employees
Pricing
Likely Fixed Price
Est. Level of Competition
Low
Odds of Award
29%
Signs of Shaping
The solicitation is open for 6 days, below average for the Food and Drug Administration.
On 5/5/26 Food and Drug Administration issued Sources Sought CDHR-2026-133666 for Adaptive Optics (AO) Retinal Imaging System due 5/12/26. The opportunity was issued full & open with NAICS 334510 and PSC 6640.
Primary Contact
Name
Freshta Javid   Profile
Phone
13017960385

Documents

Posted documents for Sources Sought CDHR-2026-133666

Opportunity Assistant


AI Analysis

AI Generate

Incumbent or Similar Awards

Contracts Similar to Sources Sought CDHR-2026-133666

Potential Bidders and Partners

Awardees that have won contracts similar to Sources Sought CDHR-2026-133666

Similar Active Opportunities

Open contract opportunities similar to Sources Sought CDHR-2026-133666

Experts for Adaptive Optics (AO) Retinal Imaging System

Recommended subject matter experts available for hire

Additional Details

Source Agency Hierarchy
HEALTH AND HUMAN SERVICES, DEPARTMENT OF > FOOD AND DRUG ADMINISTRATION > FDA OFFICE OF ACQ GRANT SVCS
FPDS Organization Code
7524-00223
Source Organization Code
100188033
Last Updated
May 5, 2026
Last Updated By
freshta.javid@fda.hhs.gov
Archive Date
May 13, 2026